EVAX is currently covered by 2 analysts with an average price target of $12.5. This is a potential upside of $10.25 (455.56%) from yesterday's end of day stock price of $2.25.
Evaxion Biotech AS's activity chart (see below) currently has 9 price targets and 17 ratings on display. The stock rating distribution of EVAX is 100% BUY.
Highest price target for EVAX is $16, Lowest price target is $9, average price target is $12.5.
Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 24-Apr-2026. First documented stock forecast 30-Jul-2021.
Currently out of the existing stock ratings of EVAX, 3 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Aug-2024
$16
$13.75 (611.11%)
6 months 29 days ago
(24-Apr-2026)
0/5 (0%)
$11.97 (297.02%)
Buy Since 30-Jul-2021
$9
$6.75 (300.00%)
$11
8 months 13 days ago
(09-Mar-2026)
0/4 (0%)
$5.92 (192.21%)
Which analyst most recently updated their price target on EVAX (Evaxion Biotech AS)?
Which analyst has the lowest performance score on EVAX (Evaxion Biotech AS) with a proven track record?
Which analyst has the most public recommendations on EVAX (Evaxion Biotech AS)?
Which analyst is the currently most bullish on EVAX (Evaxion Biotech AS)?
Which analyst is the currently most reserved on EVAX (Evaxion Biotech AS)?